Advertisement

Ads Placeholder
Loading...

4SC AG

VSC.DE•XETRA
Healthcare
Biotechnology
€2.98
€0.00(0.00%)
German Market opens in 4h 36m

4SC AG (VSC.DE) Stock Overview

Explore 4SC AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap150.7M
P/E Ratio-3.66
EPS (TTM)$-0.41
ROE-0.90%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

VSC.DE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of 4SC AG (VSC.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.66 and a market capitalization of 150.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
106.94%
6-Month Change
46.08%
Year-to-Date (YTD) Change
119.12%
1-Year Change
40.24%
3-Year Change
-62.16%
5-Year Change
-92.55%
All-Time (Max) Change
-96.88%

Contact Information

http://www.4sc.de
49897007630
Fraunhoferstr. 22, Planegg, BY, 82152

Company Facts

330 Employees
IPO DateFeb 25, 2008
CountryDE

Frequently Asked Questions